BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22435709)

  • 1. The impact of insulin administration during the mixed meal tolerance test.
    Besser RE; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
    Diabet Med; 2012 Oct; 29(10):1279-84. PubMed ID: 22435709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.
    Jones AG; Besser RE; McDonald TJ; Shields BM; Hope SV; Bowman P; Oram RA; Knight BA; Hattersley AT
    Diabet Med; 2011 Sep; 28(9):1034-8. PubMed ID: 21843301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.
    Hope SV; Knight BA; Shields BM; Hattersley AT; McDonald TJ; Jones AG
    Diabet Med; 2016 Nov; 33(11):1554-1558. PubMed ID: 27100275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of glucagon response on early postprandial glucose excursions irrespective of residual β-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance test.
    Ito A; Horie I; Miwa M; Sako A; Niri T; Nakashima Y; Shigeno R; Haraguchi A; Natsuda S; Akazawa S; Kamada A; Kawakami A; Abiru N
    J Diabetes Investig; 2021 Aug; 12(8):1367-1376. PubMed ID: 33369175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.
    Gastaldelli A; Casolaro A; Pettiti M; Nannipieri M; Ciociaro D; Frascerra S; Buzzigoli E; Baldi S; Mari A; Ferrannini E
    Clin Pharmacol Ther; 2007 Feb; 81(2):205-12. PubMed ID: 17259945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.
    Nauck MA; Weber I; Bach I; Richter S; Orskov C; Holst JJ; Schmiegel W
    Diabet Med; 1998 Nov; 15(11):937-45. PubMed ID: 9827848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.
    Besser RE; Shields BM; Casas R; Hattersley AT; Ludvigsson J
    Diabetes Care; 2013 Feb; 36(2):195-201. PubMed ID: 23111058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects.
    Marena S; Montegrosso G; De Michieli F; Pisu E; Pagano G
    Acta Diabetol; 1992; 29(1):29-33. PubMed ID: 1520903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.
    Besser RE; Ludvigsson J; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
    Diabetes Care; 2011 Mar; 34(3):607-9. PubMed ID: 21285386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal.
    Pozzilli P; Raz I; Peled D; Elias D; Avron A; Tamir M; Eren R; Dagan S; Cohen IR
    Diabetes Care; 2014; 37(5):1384-91. PubMed ID: 24408401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose.
    Maki KC; McKenney JM; Farmer MV; Reeves MS; Dicklin MR
    Nutr J; 2009 May; 8():22. PubMed ID: 19476649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.
    Rosenfalck AM; Thorsby P; Kjems L; Birkeland K; Dejgaard A; Hanssen KF; Madsbad S
    Acta Diabetol; 2000 Mar; 37(1):41-6. PubMed ID: 10928235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
    Zisser H; Renard E; Kovatchev B; Cobelli C; Avogaro A; Nimri R; Magni L; Buckingham BA; Chase HP; Doyle FJ; Lum J; Calhoun P; Kollman C; Dassau E; Farret A; Place J; Breton M; Anderson SM; Dalla Man C; Del Favero S; Bruttomesso D; Filippi A; Scotton R; Phillip M; Atlas E; Muller I; Miller S; Toffanin C; Raimondo DM; De Nicolao G; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):613-22. PubMed ID: 25003311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma C-peptide concentration in women with Type 1 diabetes during early and late pregnancy.
    Murphy HR; Elleri D; Allen JM; Simmons D; Nodale M; Hovorka R
    Diabet Med; 2012 Oct; 29(10):e361-4. PubMed ID: 22804483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.
    Hao W; Greenbaum CJ; Krischer JP; Cuthbertson D; Marks JB; Palmer JP
    Diabetes Care; 2015 May; 38(5):891-6. PubMed ID: 25720600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.
    Wakasaki H; Shono T; Nakao R; Yamamoto S; Minaga T; Fukuda S; Matsumoto R; Ohoshi T; Naka K; Nanjo K
    Intern Med; 2020; 59(18):2229-2235. PubMed ID: 32938850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
    RISE Consortium
    Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.
    Gjessing HJ; Reinholdt B; Pedersen O
    Diabetologia; 1989 Dec; 32(12):858-63. PubMed ID: 2693165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.